These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19652526

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo.
    Holen I, Walker M, Nutter F, Fowles A, Evans CA, Eaton CL, Ottewell PD.
    Clin Exp Metastasis; 2016 Mar; 33(3):211-24. PubMed ID: 26585891
    [Abstract] [Full Text] [Related]

  • 23. Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
    Ullén A, Lennartsson L, Harmenberg U, Hjelm-Eriksson M, Kälkner KM, Lennernäs B, Nilsson S.
    Acta Oncol; 2005 Mar; 44(6):644-50. PubMed ID: 16165924
    [Abstract] [Full Text] [Related]

  • 24. Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.
    Rachner TD, Singh SK, Schoppet M, Benad P, Bornhäuser M, Ellenrieder V, Ebert R, Jakob F, Hofbauer LC.
    Cancer Lett; 2010 Jan 01; 287(1):109-16. PubMed ID: 19577359
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
    Göbel A, Browne AJ, Thiele S, Rauner M, Hofbauer LC, Rachner TD.
    Breast Cancer Res Treat; 2015 Dec 01; 154(3):623-31. PubMed ID: 26515701
    [Abstract] [Full Text] [Related]

  • 28. Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid.
    Hue TF, Cummings SR, Cauley JA, Bauer DC, Ensrud KE, Barrett-Connor E, Black DM.
    JAMA Intern Med; 2014 Oct 01; 174(10):1550-7. PubMed ID: 25111880
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis.
    Russell MR, Liu Q, Fatatis A.
    Clin Cancer Res; 2010 Oct 15; 16(20):5002-10. PubMed ID: 20813817
    [Abstract] [Full Text] [Related]

  • 31. Zoledronic acid : a review of its use in the management of bone metastases of malignancy.
    Dhillon S, Lyseng-Williamson KA.
    Drugs; 2008 Oct 15; 68(4):507-34. PubMed ID: 18318568
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR, Calabro A.
    Oncology; 2006 Oct 15; 70(2):147-53. PubMed ID: 16645328
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
    McKeage K, Plosker GL.
    Pharmacoeconomics; 2008 Oct 15; 26(3):251-68. PubMed ID: 18282018
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
    Dedes PG, Kanakis I, Gialeli Ch, Theocharis AD, Tsegenidis T, Kletsas D, Tzanakakis GN, Karamanos NK.
    Biochim Biophys Acta; 2013 Jun 15; 1830(6):3625-34. PubMed ID: 23395844
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the attenuation of breast cancer bone metastasis in mice by zoledronic acid using (99m)Tc bone scintigraphy.
    Wu C, Yang S, Sun Z, Han X, Ye Y, Liu S.
    Pathol Oncol Res; 2014 Jul 15; 20(3):747-54. PubMed ID: 24610002
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.